Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R K B Pearce

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Developmental Neuroscience|February 18, 2004
Nuclear hormone and orphan receptors: their role in neuronal differentiation and cytoprotection and in the pathogenesis of Parkinson's diseaseA Malaspina, R K B Pearce, M B Graeber
Neuroscience Letters|June 16, 2009
Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodiesM E Kalaitzakis, R K B Pearce, S M Gentleman
Neuropathology and Applied Neurobiology|February 1, 2013
Disturbed sleep in Parkinson's disease: anatomical and pathological correlatesM E Kalaitzakis, S M Gentleman, R K B Pearce
Neuropathology and Applied Neurobiology|September 26, 2003
Parkinson's disease: an updateM B Graeber, D Dexter, R K B Pearce, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 21, 2013
Cholinergic manipulation of motor disability and L-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosetsM J Jackson, T Swart, R K B Pearce, et al.
Neuropathology and Applied Neurobiology|December 7, 2007
The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein stagingM E Kalaitzakis, M B Graeber, S M Gentleman, et al.
Neurogenetics|January 11, 2007
The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerabilityD C Duke, L B Moran, R K B Pearce, et al.
Neurobiology of Disease|October 19, 2010
Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromesM E Kalaitzakis, A J Walls, R K B Pearce, et al.
Neuropathology and Applied Neurobiology|February 4, 2009
Evidence against a reliable staging system of alpha-synuclein pathology in Parkinson's diseaseM E Kalaitzakis, M B Graeber, S M Gentleman, et al.
Schizophrenia Research|May 4, 2013
Oligodendrocyte density is changed in the basolateral amygdala in schizophrenia but not depressionM R Williams, H Harb, R K B Pearce, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Developmental Neuroscience|February 18, 2004
Nuclear hormone and orphan receptors: their role in neuronal differentiation and cytoprotection and in the pathogenesis of Parkinson's diseaseA Malaspina, R K B Pearce, M B Graeber
Neuroscience Letters|June 16, 2009
Clinical correlates of pathology in the claustrum in Parkinson's disease and dementia with Lewy bodiesM E Kalaitzakis, R K B Pearce, S M Gentleman
Neuropathology and Applied Neurobiology|February 1, 2013
Disturbed sleep in Parkinson's disease: anatomical and pathological correlatesM E Kalaitzakis, S M Gentleman, R K B Pearce
Neuropathology and Applied Neurobiology|September 26, 2003
Parkinson's disease: an updateM B Graeber, D Dexter, R K B Pearce, et al.
Journal of Neural Transmission (Vienna, Austria : 1996)|August 21, 2013
Cholinergic manipulation of motor disability and L-DOPA-induced dyskinesia in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-treated common marmosetsM J Jackson, T Swart, R K B Pearce, et al.
Neuropathology and Applied Neurobiology|December 7, 2007
The dorsal motor nucleus of the vagus is not an obligatory trigger site of Parkinson's disease: a critical analysis of alpha-synuclein stagingM E Kalaitzakis, M B Graeber, S M Gentleman, et al.
Neurogenetics|January 11, 2007
The medial and lateral substantia nigra in Parkinson's disease: mRNA profiles associated with higher brain tissue vulnerabilityD C Duke, L B Moran, R K B Pearce, et al.
Neurobiology of Disease|October 19, 2010
Striatal Aβ peptide deposition mirrors dementia and differentiates DLB and PDD from other parkinsonian syndromesM E Kalaitzakis, A J Walls, R K B Pearce, et al.
Neuropathology and Applied Neurobiology|February 4, 2009
Evidence against a reliable staging system of alpha-synuclein pathology in Parkinson's diseaseM E Kalaitzakis, M B Graeber, S M Gentleman, et al.
Schizophrenia Research|May 4, 2013
Oligodendrocyte density is changed in the basolateral amygdala in schizophrenia but not depressionM R Williams, H Harb, R K B Pearce, et al.
Pageof 3